Question 1

How many shares of MLTX does TD ASSET MANAGEMENT INC own?

Accepted Answer

As of 2026-Q2, TD ASSET MANAGEMENT INC holds 128,274 shares of MLTX (MoonLake Immunotherapeutics Class A).

Question 2

What is TD ASSET MANAGEMENT INC's MLTX position worth?

Accepted Answer

As of 2026-Q2, TD ASSET MANAGEMENT INC's MLTX position is worth $2.5M.

Question 3

Is TD ASSET MANAGEMENT INC buying or selling MLTX?

Accepted Answer

In 2026-Q2, TD ASSET MANAGEMENT INC decreased their MLTX position (-10.1% change in shares).

Question 4

When did TD ASSET MANAGEMENT INC first buy MLTX?

Accepted Answer

Based on available 13F filings, TD ASSET MANAGEMENT INC first reported a position in MLTX in 2024-Q3. They have held the position across 17 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	128,274	-10.1%	$2.5M	0.0%	$19.47	0
2026-Q1	Increased	142,706	+12.6%	$2.7M	0.0%	$17.69	30
2025-Q4	Increased	126,744	+18.9%	$1.7M	0.0%	$13.21	30
2025-Q3	Decreased	106,610	-42.7%	$764,394	0.0%	$6.24	0
2025-Q2	Decreased	186,152	-14.2%	$8.8M	0.0%	$47.52	0
2025-Q1	Decreased	216,904	-17.1%	$8.5M	0.0%	$39.86	0
2024-Q4	Increased	261,634	+21.2%	$14.2M	0.0%	$53.02	34
2024-Q3	Increased	215,834	+3.1%	$10.7M	0.0%	$49.40	29